242.0: Sunday, October 21, 2001 - 2:00 PM

Abstract #22099

SESSION ABSTRACT - Funding for ATOD research at the National Institutes of Health

Michele Bloch, MD, PhD, NCI, Harold Perl, Health Services Research Branch, Division of Clinical and Prevention Research, NIAAA, 6000 Executive Blvd, MSC 7003, Bethesda, MD, and Lucinda Miner, PhD, National Institute on Drug Abuse, 301-443-6071, cminer@mail.nih.gov.

The overall goal of this session is to increase the ability of researchers, both new and experienced, to secure funding for research and training from the National Institutes of Health (NIH). The session will focus primarily on research and training within the alcohol, tobacco and other drug (ATOD) field, with a special emphasis on assisting researchers from public health disciplines. However, the session will address issues applicable to a broad range of investigators. The first presentation will provide an overview of the NIH and its numerous Institutes and Centers. It will consider in more detail the three Institutes that provide the majority of federal funding for ATOD research: the National Cancer Institute (NCI); the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA). The second presentation will emphasize the application process for research and training. It will overview the many different funding mechanisms available, the peer-review process and the research interests of the three major ATOD funders. The final presentation will focus on providing specific suggestions for applicants to improve the quality of their applications and to utilize the expertise of NIH program staff.

Learning Objectives: At the conclusion of this session, the participant will be: 1. Familiar with the structure of the NIH and the ATOD research/training granting Institutes. 2. Understand the process by which applicants are judged for scientific merit and funding. 3. Recognize the ways in which program staff can be of service to new and seasoned investigators.

Keywords: Alcohol, Drug Abuse

The 129th Annual Meeting of APHA